{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:11:18Z","timestamp":1791087078972,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"8083","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,10,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Both single nucleotide variants (SNVs) and somatic copy number alterations (SCNAs) accumulate in cancer cells during tumour development, fuelling clonal evolution. However, accurate estimation of clone-specific copy numbers from bulk DNA-sequencing data is challenging. Here we present allele-specific phylogenetic analysis of copy number alterations (ALPACA), a method to infer SNV and SCNA coevolution by leveraging phylogenetic trees reconstructed from multi-sample bulk tumour sequencing data using SNV frequencies. ALPACA estimates the SCNA evolution of simulated tumours with a higher accuracy than current state-of-the-art methods<jats:sup>1\u20134<\/jats:sup>. ALPACA uncovers loss-of-heterozygosity and amplification events in minor clones that may be missed using standard approaches and reveals the temporal order of somatic alterations. Analysing clone-specific copy numbers in TRACERx421 lung tumours<jats:sup>5,6<\/jats:sup>, we find evidence of increased chromosomal instability in metastasis-seeding clones and enrichment for losses affecting tumour suppressor genes and amplification affecting <jats:italic>CCND1<\/jats:italic>. Furthermore, we identify increased SCNA rates in both tumours with polyclonal metastatic dissemination and tumours with extrathoracic metastases, and an association between higher clone copy number diversity and reduced disease-free survival in patients with lung cancer.<\/jats:p>","DOI":"10.1038\/s41586-025-09398-w","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:03:44Z","timestamp":1755097424000},"page":"190-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clone copy number diversity is linked to survival in lung cancer"],"prefix":"10.1038","volume":"646","author":[{"given":"Piotr","family":"Pawlik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8435-0176","authenticated-orcid":false,"given":"Kristiana","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Bunkum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Coggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0341-7878","authenticated-orcid":false,"given":"Alexander M.","family":"Frankell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4817-0565","authenticated-orcid":false,"given":"Carlos","family":"Martinez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6863-2360","authenticated-orcid":false,"given":"Takahiro","family":"Karasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-4999","authenticated-orcid":false,"given":"Ariana","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4477-9047","authenticated-orcid":false,"given":"Jasmin","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5570-5070","authenticated-orcid":false,"given":"Allan","family":"Hackshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-3018","authenticated-orcid":false,"given":"Charles","family":"Swanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5265-7392","authenticated-orcid":false,"given":"Simone","family":"Zaccaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9537-4045","authenticated-orcid":false,"given":"Nicholas","family":"McGranahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"9398_CR1","doi-asserted-by":"publisher","first-page":"i125","DOI":"10.1093\/bioinformatics\/btac253","volume":"38","author":"X Fu","year":"2022","unstructured":"Fu, X., Lei, H., Tao, Y. & Schwartz, R. Reconstructing tumor clonal lineage trees incorporating single-nucleotide variants, copy number alterations and structural variations. Bioinformatics 38, i125\u2013i133 (2022).","journal-title":"Bioinformatics"},{"key":"9398_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17967-y","volume":"11","author":"S Zaccaria","year":"2020","unstructured":"Zaccaria, S. & Raphael, B. J. Accurate quantification of copy-number aberrations and whole-genome duplications in multi-sample tumor sequencing data. Nat. Commun. 11, 4301 (2020).","journal-title":"Nat. Commun."},{"key":"9398_CR3","doi-asserted-by":"crossref","unstructured":"Myers, M. A. et al. HATCHet2: clone- and haplotype-specific copy number inference from bulk tumor sequencing data. Genome Biol. 25, 130 (2024).","DOI":"10.1186\/s13059-024-03267-x"},{"key":"9398_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02794-9","volume":"23","author":"TL Kaufmann","year":"2022","unstructured":"Kaufmann, T. L. et al. MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. Genome Biol. 23, 241 (2022).","journal-title":"Genome Biol."},{"key":"9398_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41586-023-05783-5","volume":"616","author":"AM Frankell","year":"2023","unstructured":"Frankell, A. M. et al. The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 616, 525\u2013533 (2023).","journal-title":"Nature"},{"key":"9398_CR6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41586-023-05729-x","volume":"616","author":"M Al Bakir","year":"2023","unstructured":"Al Bakir, M. et al. The evolution of non-small cell lung cancer metastases in TRACERx. Nature 616, 534\u2013542 (2023).","journal-title":"Nature"},{"key":"9398_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306\u2013313 (2012).","journal-title":"Nature"},{"key":"9398_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ng1768","volume":"38","author":"CC Maley","year":"2006","unstructured":"Maley, C. C. et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet. 38, 468\u2013473 (2006).","journal-title":"Nat. Genet."},{"key":"9398_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23384-6","volume":"12","author":"E van Dijk","year":"2021","unstructured":"van Dijk, E. et al. Chromosomal copy number heterogeneity predicts survival rates across cancers. Nat. Commun. 12, 3188 (2021).","journal-title":"Nat. Commun."},{"key":"9398_CR10","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","volume":"376","author":"M Jamal-Hanjani","year":"2017","unstructured":"Jamal-Hanjani, M. et al. Tracking the evolution of non-small-cell lung cancer. N. Engl. J. Med. 376, 2109\u20132121 (2017).","journal-title":"N. Engl. J. Med."},{"key":"9398_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-023-05776-4","volume":"616","author":"C Abbosh","year":"2023","unstructured":"Abbosh, C. et al. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature 616, 553\u2013562 (2023).","journal-title":"Nature"},{"key":"9398_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029611","volume":"7","author":"SF Bakhoum","year":"2017","unstructured":"Bakhoum, S. F. & Landau, D. A. Chromosomal instability as a driver of tumor heterogeneity and evolution. Cold Spring Harb. Perspect. Med. 7, a029611 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"9398_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/science.959840","volume":"194","author":"PC Nowell","year":"1976","unstructured":"Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23\u201328 (1976).","journal-title":"Science"},{"key":"9398_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994\u20131007 (2012).","journal-title":"Cell"},{"key":"9398_CR15","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1101\/gr.180281.114","volume":"24","author":"G Ha","year":"2014","unstructured":"Ha, G. et al. TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data. Genome Res. 24, 1881\u20131893 (2014).","journal-title":"Genome Res."},{"key":"9398_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-7-r80","volume":"14","author":"L Oesper","year":"2013","unstructured":"Oesper, L., Mahmoody, A. & Raphael, B. J. THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data. Genome Biol. 14, R80 (2013).","journal-title":"Genome Biol."},{"key":"9398_CR17","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/nprot.2018.033","volume":"13","author":"Y Cun","year":"2018","unstructured":"Cun, Y., Yang, T.-P., Achter, V., Lang, U. & Peifer, M. Copy-number analysis and inference of subclonal populations in cancer genomes using Sclust. Nat. Protoc. 13, 1488\u20131501 (2018).","journal-title":"Nat. Protoc."},{"key":"9398_CR18","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.celrep.2014.04.055","volume":"7","author":"A Fischer","year":"2014","unstructured":"Fischer, A., V\u00e1zquez-Garc\u00eda, I., Illingworth, C. J. R. & Mustonen, V. High-definition reconstruction of clonal composition in cancer. Cell Rep. 7, 1740\u20131752 (2014).","journal-title":"Cell Rep."},{"key":"9398_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1267-2","volume":"18","author":"AW McPherson","year":"2017","unstructured":"McPherson, A. W. et al. ReMixT: clone-specific genomic structure estimation in cancer. Genome Biol. 18, 140 (2017).","journal-title":"Genome Biol."},{"key":"9398_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14844-6","volume":"11","author":"B Werner","year":"2020","unstructured":"Werner, B. et al. Measuring single cell divisions in human tissues from multi-region sequencing data. Nat. Commun. 11, 1035 (2020).","journal-title":"Nat. Commun."},{"key":"9398_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41596-023-00913-9","volume":"19","author":"K Grigoriadis","year":"2024","unstructured":"Grigoriadis, K. et al. CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction. Nat. Protoc. 19, 159\u2013183 (2024).","journal-title":"Nat. Protoc."},{"key":"9398_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cels.2016.07.004","volume":"3","author":"M El-Kebir","year":"2016","unstructured":"El-Kebir, M., Satas, G., Oesper, L. & Raphael, B. J. Inferring the mutational history of a tumor Ising multi-state perfect phylogeny mixtures. Cell Syst. 3, 43\u201353 (2016).","journal-title":"Cell Syst."},{"key":"9398_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0647-8","volume":"16","author":"V Popic","year":"2015","unstructured":"Popic, V. et al. Fast and scalable inference of multi-sample cancer lineages. Genome Biol. 16, 91 (2015).","journal-title":"Genome Biol."},{"key":"9398_CR24","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1093\/bioinformatics\/btv003","volume":"31","author":"S Malikic","year":"2015","unstructured":"Malikic, S., McPherson, A. W., Donmez, N. & Sahinalp, C. S. Clonality inference in multiple tumor samples using phylogeny. Bioinformatics 31, 1349\u20131356 (2015).","journal-title":"Bioinformatics"},{"key":"9398_CR25","doi-asserted-by":"publisher","first-page":"E5528","DOI":"10.1073\/pnas.1522203113","volume":"113","author":"Y Jiang","year":"2016","unstructured":"Jiang, Y., Qiu, Y., Minn, A. J. & Zhang, N. R. Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing. Proc. Natl Acad. Sci. USA 113, E5528\u2013E5537 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9398_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1158\/2643-3230.BCD-21-0092","volume":"3","author":"JA Wintersinger","year":"2022","unstructured":"Wintersinger, J. A. et al. Reconstructing complex cancer evolutionary histories from multiple bulk DNA samples using pairtree. Blood Cancer Discov. 3, 208\u2013219 (2022).","journal-title":"Blood Cancer Discov."},{"key":"9398_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.cels.2019.05.010","volume":"8","author":"MA Myers","year":"2019","unstructured":"Myers, M. A., Satas, G. & Raphael, B. J. CALDER: inferring phylogenetic trees from longitudinal tumor samples. Cell Syst. 8, 514\u2013522 (2019).","journal-title":"Cell Syst."},{"key":"9398_CR28","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.1073\/pnas.1009843107","volume":"107","author":"P Van Loo","year":"2010","unstructured":"Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910\u201316915 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9398_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64\u201370 (2015).","journal-title":"Ann. Oncol."},{"key":"9398_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011379","volume":"19","author":"TBK Watkins","year":"2023","unstructured":"Watkins, T. B. K. et al. Refphase: multi-sample phasing reveals haplotype-specific copy number heterogeneity. PLoS Comput. Biol. 19, e1011379 (2023).","journal-title":"PLoS Comput. Biol."},{"key":"9398_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1089\/cmb.2017.0253","volume":"25","author":"S Zaccaria","year":"2018","unstructured":"Zaccaria, S., El-Kebir, M., Klau, G. W. & Raphael, B. J. Phylogenetic copy-number factorization of multiple tumor samples. J. Comput. Biol. 25, 689\u2013708 (2018).","journal-title":"J. Comput. Biol."},{"key":"9398_CR32","doi-asserted-by":"publisher","unstructured":"El-Kebir, M. et al. in Lecture Notes in Computer Science (ed. Frith, M.) 137\u2013149 (Springer, 2016); https:\/\/doi.org\/10.1007\/978-3-319-43681-4_11.","DOI":"10.1007\/978-3-319-43681-4_11"},{"key":"9398_CR33","doi-asserted-by":"publisher","unstructured":"Zaccaria, S., El-Kebir, M., Klau, G. W. & Raphael, B. J. in Lecture Notes in Computer Science (ed. Sahinalp, S. C.) 318\u2013335 (Springer, 2017); https:\/\/doi.org\/10.1007\/978-3-319-56970-3_20.","DOI":"10.1007\/978-3-319-56970-3_20"},{"key":"9398_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41588-024-01989-z","volume":"57","author":"O Lucas","year":"2025","unstructured":"Lucas, O. et al. Characterizing the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER. Nat. Genet. 57, 103\u2013114 (2025).","journal-title":"Nat. Genet."},{"key":"9398_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41587-020-0661-6","volume":"39","author":"S Zaccaria","year":"2021","unstructured":"Zaccaria, S. & Raphael, B. J. Characterizing allele- and haplotype-specific copy numbers in single cells with CHISEL. Nat. Biotechnol. 39, 207\u2013214 (2021).","journal-title":"Nat. Biotechnol."},{"key":"9398_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-019-1907-7","volume":"578","author":"M Gerstung","year":"2020","unstructured":"Gerstung, M. et al. The evolutionary history of 2,658 cancers. Nature 578, 122\u2013128 (2020).","journal-title":"Nature"},{"key":"9398_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27472-5","volume":"12","author":"BA Benard","year":"2021","unstructured":"Benard, B. A. et al. Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia. Nat. Commun. 12, 7244 (2021).","journal-title":"Nat. Commun."},{"key":"9398_CR38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-020-2698-6","volume":"587","author":"TBK Watkins","year":"2020","unstructured":"Watkins, T. B. K. et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587, 126\u2013132 (2020).","journal-title":"Nature"},{"key":"9398_CR39","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41588-020-0592-7","volume":"52","author":"DJH Shih","year":"2020","unstructured":"Shih, D. J. H. et al. Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma. Nat. Genet. 52, 371\u2013377 (2020).","journal-title":"Nat. Genet."},{"key":"9398_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-023-05706-4","volume":"616","author":"C Mart\u00ednez-Ruiz","year":"2023","unstructured":"Mart\u00ednez-Ruiz, C. et al. Genomic-transcriptomic evolution in lung cancer and metastasis. Nature 616, 543\u2013552 (2023).","journal-title":"Nature"},{"key":"9398_CR41","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","volume":"606","author":"CD Steele","year":"2022","unstructured":"Steele, C. D. et al. Signatures of copy number alterations in human cancer. Nature 606, 984\u2013991 (2022).","journal-title":"Nature"},{"key":"9398_CR42","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41586-022-04789-9","volume":"606","author":"RM Drews","year":"2022","unstructured":"Drews, R. M. et al. A pan-cancer compendium of chromosomal instability. Nature 606, 976\u2013983 (2022).","journal-title":"Nature"},{"key":"9398_CR43","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41588-018-0179-8","volume":"50","author":"G Macintyre","year":"2018","unstructured":"Macintyre, G. et al. Copy number signatures and mutational processes in ovarian carcinoma. Nat. Genet. 50, 1262\u20131270 (2018).","journal-title":"Nat. Genet."},{"key":"9398_CR44","doi-asserted-by":"publisher","unstructured":"Frankell, A. M., Colliver, E., McGranahan, N. & Swanton, C. cloneMap: a R package to visualise clonal heterogeneity. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.07.26.501523 (2022).","DOI":"10.1101\/2022.07.26.501523"},{"key":"9398_CR45","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen, R. & Seshan, V. E. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 44, e131 (2016).","journal-title":"Nucleic Acids Res."},{"key":"9398_CR46","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"9398_CR47","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nmeth.2883","volume":"11","author":"A Roth","year":"2014","unstructured":"Roth, A. et al. PyClone: statistical inference of clonal population structure in cancer. Nat. Methods 11, 396\u2013398 (2014).","journal-title":"Nat. Methods"},{"key":"9398_CR48","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12859-020-03919-2","volume":"21","author":"S Gillis","year":"2020","unstructured":"Gillis, S. & Roth, A. PyClone-VI: scalable inference of clonal population structures using whole genome data. BMC Bioinform. 21, 571 (2020).","journal-title":"BMC Bioinform."},{"key":"9398_CR49","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.cels.2021.07.006","volume":"12","author":"G Satas","year":"2021","unstructured":"Satas, G., Zaccaria, S., El-Kebir, M. & Raphael, B. J. DeCiFering the elusive cancer cell fraction in tumor heterogeneity and evolution. Cell Syst 12, 1004\u20131018 (2021).","journal-title":"Cell Syst"},{"key":"9398_CR50","doi-asserted-by":"publisher","unstructured":"Satopaa, V., Albrecht, J., Irwin, D. & Raghavan, B. Finding a \u2018kneedle\u2019 in a haystack: detecting knee points in system behavior. In Proc. 2011 31st International Conference on Distributed Computing Systems Workshops 166\u2013171 (IEEE, 2011); https:\/\/doi.org\/10.1109\/ICDCSW.2011.20.","DOI":"10.1109\/ICDCSW.2011.20"},{"key":"9398_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v048.i09","volume":"48","author":"H Turner","year":"2012","unstructured":"Turner, H. & Firth, D. Bradley-Terry models in R: the BradleyTerry2 package. J. Stat. Softw. 48, 1\u201321 (2012).","journal-title":"J. Stat. Softw."},{"key":"9398_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13015-017-0103-2","volume":"12","author":"M El-Kebir","year":"2017","unstructured":"El-Kebir, M. et al. Complexity and algorithms for copy-number evolution problems. Algorithms Mol. Biol. 12, 13 (2017).","journal-title":"Algorithms Mol. Biol."},{"key":"9398_CR53","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/cmb.2017.0060","volume":"24","author":"R Zeira","year":"2017","unstructured":"Zeira, R., Zehavi, M. & Shamir, R. A linear-time algorithm for the copy number transformation problem. J. Comput. Biol. 24, 1179\u20131194 (2017).","journal-title":"J. Comput. Biol."},{"key":"9398_CR54","doi-asserted-by":"publisher","unstructured":"TRACERx consortium. The evolution of lung cancer and impact of subclonal selection in TRACERx. Zenodo https:\/\/doi.org\/10.5281\/zenodo.7822002 (2023).","DOI":"10.5281\/zenodo.7822002"},{"key":"9398_CR55","doi-asserted-by":"publisher","unstructured":"Lucas, O., Zaidi, R., Bunkum, A. & Zaccaria, S. Processed data for \u201cCharacterising the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER\u201d. Zenodo https:\/\/doi.org\/10.5281\/zenodo.13754279 (2024).","DOI":"10.5281\/zenodo.13754279"},{"key":"9398_CR56","doi-asserted-by":"publisher","unstructured":"Pawlik, P. & Grigoriadis, K. Processed data for \u201cClone copy number diversity is linked to survival in lung cancer\u201d. Zenodo https:\/\/doi.org\/10.5281\/zenodo.15519765 (2025).","DOI":"10.5281\/zenodo.15519765"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09398-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09398-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09398-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T04:03:18Z","timestamp":1759723398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09398-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":56,"journal-issue":{"issue":"8083","published-print":{"date-parts":[[2025,10,2]]}},"alternative-id":["9398"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09398-w","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A. Hackshaw has received fees for being a member of independent data monitoring committees for Roche-sponsored clinical trials and academic projects coordinated by Roche. N.M. holds patents related to determining human leukocyte antigen (HLA) LOH (PCT\/GB2018\/052004), determination of B cell fraction in mixed samples (PCT\/EP2024\/062999), determination of lymphocyte abundance in mixed samples (PCT\/EP2022\/070694), identifying responders to cancer treatment (PCT\/GB2018\/051912), targeting neoantigens (PCT\/EP2016\/059401), identifying patient response to immune checkpoint blockade (PCT\/EP2016\/071471) and predicting survival rates of patients with cancer (PCT\/GB2020\/050221) and has a patent pending in determining HLA disruption (PCT\/EP2023\/059039). C.S. acknowledges grant support from AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Pfizer, Invitae (previously Archer Dx\u2014collaboration in minimal residual disease sequencing technologies), Ono Pharmaceutical and Personalis; is chief investigator for the AZ MeRmaiD 1 and 2 clinical trials and is the Steering Committee chair; is co-chief investigator of the NHS Galleri trial financed by GRAIL and a paid member of GRAIL\u2019s Scientific Advisory Board (SAB); receives consultant fees from Achilles (and is also an SAB member), Bicycle Therapeutics (SAB member and chair of Clinical Advisory Group), Genentech, Medicxi, China Innovation Centre of Roche (formerly Roche Innovation Centre, Shanghai), Metabomed (until July 2022), Relay Therapeutics (SAB member), Saga Diagnostics (SAB member) and the Sarah Cannon Research Institute; has received honoraria from Amgen, AstraZeneca, Bristol Myers Squibb, GlaxoSmithKline, Illumina, MSD, Novartis and Pfizer; has previously held stock or options in GRAIL, has stock or options in Bicycle Therapeutics and Relay Therapeutics at present, and has stock and is co-founder of Achilles Therapeutics; declares patent applications for methods for lung cancer detection (PCT\/US2017\/028013, US20190106751A1), methods for targeting neoantigens (PCT\/EP2016\/059401), methods for identifying patient response to immune checkpoint blockade (PCT\/EP2016\/071471), methods for identifying patients who respond to cancer treatment (PCT\/GB2018\/051912), methods for determining HLA LOH (PCT\/GB2018\/052004), methods for predicting survival rates of patients with cancer (PCT\/GB2020\/050221), methods and systems for tumour monitoring (PCT\/EP2022\/077987), and methods for analysis of HLA allele transcriptional deregulation (PCT\/EP2023\/059039); and is an inventor on a European patent application (PCT\/GB2017\/053289) relating to assay technology to detect tumour recurrence (this patent has been licensed to a commercial entity, and under their terms of employment, C.S. is due a revenue share of any revenue generated from such licence(s)). A.M.F. is a co-inventor on a patent application to determine methods and systems for tumour monitoring (PCT\/EP2022\/077987). J.F. is a member of the SAB at DAiNA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}